These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 141383)

  • 1. Dermatologic investigation of betamethasone 17,21-dipropionate ointment with chinoform.
    Tollofsrud A
    J Int Med Res; 1977; 5(2):132-5. PubMed ID: 141383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on the therapeutic activity of a betamethasone dipropionate - iodochloroxyquinoline combination for topical use].
    Sartoris S; Paggio A; De Santolo GP
    G Ital Dermatol Venereol; 1983; 118(6):LI-LIV. PubMed ID: 6232210
    [No Abstract]   [Full Text] [Related]  

  • 3. Betamethasone dipropionate (0.05)% plus chinoform (3%) cream against betamethasone valerate (0.1%) plus chinoform cream (3%) in secondarily infected dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Jul; 32(3):73-6. PubMed ID: 2973437
    [No Abstract]   [Full Text] [Related]  

  • 4. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 5. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
    Mensing H; Korsukewitz G; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
    Nolting S; Hagemeier HH
    Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous absorption of betamethasone-17, 21-dipropionate and salicylic acid during the treatment of psoriasis and eczema.
    Gip L; Hamfelt A
    J Int Med Res; 1976; 4(2):106-10. PubMed ID: 799983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
    Leibsohn E
    J Int Med Res; 1982; 10(1):22-7. PubMed ID: 7073809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.
    Hall-Smith P
    Br J Clin Pract; 1972 Sep; 26(9):422-3. PubMed ID: 4562674
    [No Abstract]   [Full Text] [Related]  

  • 13. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV; Kragballe K
    Int J Dermatol; 2006 Aug; 45(8):970-5. PubMed ID: 16911387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical treatment of glucocorticoid-sensitive dermatoses with diflorasone diacetate].
    Rozman TA
    Z Hautkr; 1986 Mar; 61(5):294, 297-304. PubMed ID: 3962411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
    Shupack JL; Jondreau L; Kenny C; Stiller MJ
    Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Our experience in the treatment of various dermatoses with a polyvalent topical drug].
    Casas Marin M; Sánchez del Rio J; Curto Iglesias JR
    Actas Dermosifiliogr; 1979; 70(5-6):415-20. PubMed ID: 158294
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
    Roberts DT
    Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
    Sandoval LF; Huang KE; Harrison J; Clark A; Feldman SR
    Cutis; 2014 Dec; 94(6):304-9. PubMed ID: 25566573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.